Assessing the Preliminary Effects of a Multisectoral Agricultural Intervention on Adolescent Girls' Health

October 5, 2020 updated by: University of California, San Francisco

Shamba Maisha: Assessing the Preliminary Effects of a Multisectoral Agricultural Intervention on the Sexual and Reproductive Health of HIV-affected Adolescent Girls in Western Kenya

The goal of this study is to understand how the Shamba Maisha household agricultural and economic intervention impacts the sexual, reproductive, and nutritional health of adolescent girls. The intervention includes: a) a human-powered water pump and other required farm commodities, b) a micro-finance loan (~$75) to purchase the pump and agricultural implements, and c) education in sustainable farming practices.

Study Overview

Detailed Description

Food insecurity (FI) and poverty are important drivers of HIV vulnerability among adolescent girls, and contribute to worse sexual and reproductive health (SRH) outcomes. While most approaches to improving adolescent SRH outcomes have focused on individual-centered approaches alone, integrated family-level interventions that address the underlying context for risk behaviors such as poverty and FI may be more effective in reducing adverse SRH outcomes. A household-level multisectoral agricultural and finance intervention in Nyanza Region, Kenya called Shamba Maisha (SM) designed to mitigate household FI and improve health in HIV-affected households has been successfully developed and piloted. In mid-2016, a large cluster-randomized controlled trial (RCT) of SM was launched, targeting 704 adults and 352 young children to test the effectiveness of this intervention. This pilot study leverages the SM RCT infrastructure to recruit up to 240 adolescent girls residing in SM households and assess the impact of the SM intervention at the household level on adolescent girls' SRH outcomes at study endline. The central hypothesis is that improvements in household FI and wealth will contribute to reduced sexually transmitted infections (STIs), HIV, and unintended pregnancies among adolescent girls. To test this hypothesis, demographic, behavioral, clinical, and biological data from adolescent girls and their caregivers living in intervention and control SM households will be collected. The primary outcomes are food security, depressive symptoms, and sexual risk behaviors in the adolescent girls. The secondary outcomes are pregnancy/unintended pregnancy, HIV, herpes simplex virus 2 (HSV-2), and nutritional status in the adolescent girl.

The ultimate goal is to develop an intervention tailored specifically to the needs of adolescent girls to help reverse the cycle of FI, poverty, low empowerment, and poor SRH outcomes among adolescent girls. If proven efficacious, the proposed intervention may: 1) halt or slow down the cycle of incident HIV, other STIs, and unintended pregnancies to improve the lives of adolescent girls in similar settings, and 2) help achieve several top Sustainable Development Goals (SDG) including SDG 1 (zero poverty), SDG 2 (zero hunger), SDG 3 (good health and wellbeing), and SDG 5 (gender equality).

Study Type

Interventional

Enrollment (Actual)

241

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kisumu, Kenya
        • Hongo Ogosa
      • Kisumu, Kenya
        • Kisumu District Hospital
      • Kisumu, Kenya
        • Lumumba
      • Kisumu, Kenya
        • Nyangande
      • Kisumu, Kenya
        • Pandiperi
      • Kisumu, Kenya
        • Railways
      • Kisumu, Kenya
        • Osingo
      • Migori, Kenya
        • Suna Ragana
    • Homa Bay
      • Suba, Homa Bay, Kenya
        • Kitare
      • Suba, Homa Bay, Kenya
        • Sindo
    • Migori
      • Nyatike, Migori, Kenya
        • Muhuru Bay
      • Nyatike, Migori, Kenya
        • Sori Lakeside
      • Rongo, Migori, Kenya
        • Minyenya
      • Rongo, Migori, Kenya
        • Ngode
      • Rongo, Migori, Kenya
        • Oyani
      • Uriri, Migori, Kenya
        • Nyamasare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • an adult participating in the parent study
  • a currently unmarried adolescent girl aged 13-20 years old (preferred target of 15-19)
  • the adolescent girl has a parent/primary guardian age >18 years old who resides in the household

Exclusion Criteria:

  • adolescent girls with a confirmed HIV diagnosis by clinical records prior to the start of SM
  • married adolescent girls
  • those who do not speak Dholuo, Swahili, or English
  • those who are heads of households
  • those ages 18 to 20 who are enrolled in the parent study
  • those with inadequate cognitive and/or hearing capacity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants enrolled at one study location will receive the Multi-sectoral agricultural intervention as specified below under the intervention.
Adult participants in the intervention arm receive a loan (~$175) from a well-established Kenyan bank used to get a human-powered water pump, seeds, fertilizers and, pesticides, and education in financial management and sustainable farming practices.
No Intervention: No intervention
During the study, participants enrolled at one study location will non receive the Multi-sectoral agricultural intervention. At the end of the study, participants in this arm will be eligible for education in financial management and sustainable farming practices and those who pay the loan down payment will be eligible for a small loan to purchase a human-powered water pump, seeds, fertilizers and, pesticides.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food insecurity
Time Frame: Endline / 2 years
Food insecurity as assessed by the Household Food Insecurity Access Scale (HFIAS; score range 0-27 [least to most food insecure]).
Endline / 2 years
Depressive symptoms
Time Frame: Endline / 2 years
Depression, assessed by the 15 item Hopkins Symptom Checklist-Depression (score range 1-4 [least to most depressed].
Endline / 2 years
Unprotected sex
Time Frame: Endline / 2 years
Percentage of time not used condoms over past six months
Endline / 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of participants who become pregnant
Time Frame: Endline / 2 years
Measured by urine pregnancy test
Endline / 2 years
Unintended pregnancy
Time Frame: Endline / 2 years
Unintended pregnancy as assessed by the London Measure of Unplanned Pregnancy
Endline / 2 years
HIV
Time Frame: Endline / 2 years
Serial rapid HIV tests based on the Kenyan Ministry of Health guidelines
Endline / 2 years
HSV-2
Time Frame: Endline / 2 years
HSV-2 by Kalon assay (Herpes Simplex Type 2 IgG ELISA, Kalon Biologics, Ltd.)
Endline / 2 years
Body mass index-for-age-Z-score
Time Frame: Endline / 2 years
Weight and height will be combined to report BMI in kg/m^2 as Z score
Endline / 2 years
Physical health
Time Frame: Endline / 2 years
Assessed by the Medical Outcomes Study Short Form (SF-36, score range 0-100 [poor to excellent health])
Endline / 2 years
Number of sexual partners
Time Frame: Endline / 2 years
Number of sexual partners over past six months
Endline / 2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: Endline / 2 years
Measured by the Generalized Anxiety Disorder Scale (GAD-7, 0-21 [least to most anxious]).
Endline / 2 years
Empowerment
Time Frame: Endline / 2 years
Measured by the Child and Youth Resilience Measure (CYRM-12, score range 12-60 [least to most resilient]).
Endline / 2 years
School attendance
Time Frame: Endline / 2 years
Days of school missed in previous term
Endline / 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sheri D Weiser, MD, MPH, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2018

Primary Completion (Actual)

December 20, 2019

Study Completion (Actual)

December 20, 2019

Study Registration Dates

First Submitted

November 7, 2018

First Submitted That Met QC Criteria

November 13, 2018

First Posted (Actual)

November 15, 2018

Study Record Updates

Last Update Posted (Actual)

October 8, 2020

Last Update Submitted That Met QC Criteria

October 5, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1R21HD095739 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Behavior

Clinical Trials on Multi-sectoral agricultural intervention

3
Subscribe